CompletedNot Applicable

ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2

United States995 participantsStarted 2017-02-15

Plain-language summary

This trial will test a decision support web based intervention for women at increased risk for breast cancer due to breast density and other risk factors (age, race/ethnicity, family history of breast cancer, history of prior breast biopsies), and to consider MRI and/or chemoprevention to manage their breast cancer risk.

Who can participate

Age range40 Years – 69 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women, aged 40-69 * Enrolled at Group Health * Have had a negative mammogram as part of their routine care * Either (a) an intermediate 5-year risk (\>1.67%-2.49%) and extremely dense breasts or (b) a high 5-year risk (≥2.50%) and either heterogeneously dense or extremely dense breasts utilizing the Breast Cancer Surveillance Consortium Risk Calculator (http://tools.bcsc-scc.org/BC5yearRisk/) * Women must also have a valid email address. Exclusion Criteria: * Not able to speak and read English * History of LCIS * Prior cancer diagnosis (including DCIS) * Known BRCA1/2 family mutation, or previous receipt of cancer genetic counseling * Do not want to be contacted for research * Have previously participated in intervention development activities * Dis-enrolled from health plan between mammogram and start of recruitment.

What they're measuring

Number of Participants Taking Chemoprevention at 12 Months

Timeframe: 12 months

Trial details

NCT IDNCT03029286

SponsorGeorgetown University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-15

Results submitted2025-03-20

View on ClinicalTrials.gov More Breast Density trials